Peter B Luppa

发表

Clinically relevant analytical techniques, organizational concepts for application and future perspectives of point-of-care testing.

Christopher Beaudoin, Ambra Giannetti, Andreas Bietenbeck, 2016, Biotechnology advances.

Stronger Together: Aggregated Z-values of Traditional Quality Control Measurements and Patient Medians Improve Detection of Biases.

Frank Klawonn, Andreas Bietenbeck, Peter B Luppa, 2017, Clinical chemistry.

Highly sensitive immunodiagnostics at the point of care employing alternative recognition elements and smartphones: hype, trend, or revolution?

Peter B Luppa, Markus Thaler, P. Luppa, 2019, Analytical and Bioanalytical Chemistry.

Recent advances in immunodiagnostics based on biosensor technologies—from central laboratory to the point of care

Ralf Junker, Peter B Luppa, Markus Thaler, 2019, Analytical and Bioanalytical Chemistry.

External quality assessment schemes for glucose measurements in Germany: factors for successful participation, analytical performance and medical impact

Frank Klawonn, Michael Spannagl, Christof Winter, 2018, Clinical chemistry and laboratory medicine.

Emerging Technologies for Next-Generation Point-of-Care Testing.

Aydogan Ozcan, Leslie Y Yeo, Sandeep Kumar Vashist, 2015, Trends in biotechnology.

Biosensor-based detection of reduced sex hormone-binding globulin binding capacities in response to growth-promoter administrations.

Peter B Luppa, P. Luppa, C. Elliott, 2009, Analytica chimica acta.

Syntheses and ligand-binding studies of 1α- and 17α-aminoalkyl dihydrotestosterone derivatives to human sex hormone-binding globulin

Peter B Luppa, J. Metzger, P. Luppa, 2003, Steroids.

Point-of-care testing in hospitals and primary care.

Ralf Junker, Peter B Luppa, R. Junker, 2010, Deutsches Arzteblatt international.

Development of a new parallelized, optical biosensor platform for label-free detection of autoimmunity-related antibodies

Günter Gauglitz, Oliver Bleher, Peter B Luppa, 2014, Analytical and Bioanalytical Chemistry.

Clinically relevant lot-to-lot reagent difference in a commercial immunoturbidimetric assay for glycated hemoglobin A1c.

Andreas Bietenbeck, Peter B Luppa, P. Luppa, 2015, Clinical biochemistry.

Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.

Peter B Luppa, Alexander Buhl, K. Lackner, 2007, Clinical chemistry.

Murine TLR2 expression analysis and systemic antagonism by usage of specific monoclonal antibodies.

Stefan Bauer, Hermann Wagner, Peter B Luppa, 2005, Immunology letters.

Diagnostic performance study of an antigen microarray for the detection of antiphospholipid antibodies in human serum

Günter Gauglitz, Oliver Bleher, Peter B Luppa, 2015, Clinical chemistry and laboratory medicine.

Optical biosensor-based characterization of anti-double-stranded DNA monoclonal antibodies as possible new standards for laboratory tests.

Peter B Luppa, Alexander Buhl, N. Heegaard, 2009, Biosensors & bioelectronics.

Novel biosensor-based analytic device for the detection of anti-double-stranded DNA antibodies.

Peter B Luppa, Alexander Buhl, N. Heegaard, 2007, Clinical chemistry.

Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes.

Stefan Bauer, Hermann Wagner, Peter B Luppa, 2004, The Journal of clinical investigation.